Observation on the therapeutic efficacy of budesonide and compound ipratropium bromide inhalated in treatment of infant bronchiolitis
- VernacularTitle:布地奈德联合复方异丙托溴铵雾化治疗小儿毛细支气管炎疗效观察
- Author:
Ming LI
- Publication Type:Journal Article
- Keywords:
Bronchiditis;
Budesonide;
Ipratropium bromide
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(12):2011-2012
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss the therapeutic efficacy of budesonide and compound ipratropium bromide inhalated in treatment of infant bronchiolitis.Methods From January 2005 to February 2007,150 infants with bronchiolitis were randomly divided into treated group and control group.Both the two groups were treated with comprehensive treatment and antiviral therapy;control group were treated with budesonide suspemion and compound ipratropium bromide inhalated.Clinical efficacy of both two groups was evaluated.Results Cure rate of treatment group was 91%,cure rate of control group was 71%,the clinical therapeutic efficacy were compared between the two groups,the difference of which had statistical significance.Conclusion The result of experiment indicates that the therapeutic efficacy of budesonide and compound ipratropium bromide inhalated in treatment of infant bronchiolitis is better method.
